Japan’s Prescription Dispensing Costs Increase Six Percent
This article was originally published in PharmAsia News
Japan's Central Social Insurance Council summarized July 16 electronic receipts of dispensing medical fees for fiscal year 2007.The average medical cost per prescription is ¥7,322, an increase of 5.8 percent compared to previous year. Among the two sections, cost of drugs increased by 7.5 percent to ¥5,387, compared to 1.2 percent increase in technical fees. The cost of drugs directly contributed to the medical cost increases, especially for cardiovascular treatments, which cost ¥1,360 per prescription, a 7.9 percent increase. Hypertension drugs increased 10.9 percent and followed by hyperlipidemia drugs, which increased 8.9 percent. (Click here for more - Japanese language) "Prescription Dispensing Cost Increase Nearly 6 Percent, Reported By Electronic Receipts" - Yakuji News (7/17/08)
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.